BB&T Securities’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $1.05M | Buy |
7,917
+1,556
| +24% | +$206K | 0.01% | 777 |
|
|
2019
Q2 | $902K | Buy |
6,361
+315
| +5% | +$44.7K | 0.01% | 853 |
|
|
2019
Q1 | $878K | Buy |
6,046
+697
| +13% | +$101K | 0.01% | 848 |
|
|
2018
Q4 | $605K | Sell |
5,349
-305
| -5% | -$34.5K | 0.01% | 909 |
|
|
2018
Q3 | $760K | Buy |
5,654
+2,750
| +95% | +$370K | 0.01% | 910 |
|
|
2018
Q2 | $326K | Buy |
2,904
+76
| +3% | +$8.53K | ﹤0.01% | 1234 |
|
|
2018
Q1 | $301K | Buy |
2,828
+256
| +10% | +$27.2K | ﹤0.01% | 1223 |
|
|
2017
Q4 | $281K | Sell |
2,572
-104
| -4% | -$11.4K | ﹤0.01% | 1200 |
|
|
2017
Q3 | $289K | Buy |
+2,676
| New | +$289K | ﹤0.01% | 1158 |
|